DTL
VIVO

Dynamic Technology Lab’s Meridian Bioscience Inc VIVO Stock Holding History

Dynamic Technology Lab’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-12,061
Closed -$401K – 1620
2022
Q4 		$401K Buy
12,061
+5,536
+85% +$178K 0.04% 669
2022
Q3 		$206K Buy
+6,525
New +$211K 0.02% 953
2021
Q4 		– Sell
-13,058
Closed -$251K – 1616
2021
Q3 		$251K Buy
+13,058
New +$260K 0.03% 826
2020
Q4 		– Sell
-14,776
Closed -$251K – 1455
2020
Q3 		$251K Buy
+14,776
New +$287K 0.04% 730
2019
Q3 		– Sell
-24,889
Closed -$296K – 1382
2019
Q2 		$296K Buy
+24,889
New +$300K 0.05% 654
2018
Q1 		– Sell
-19,158
Closed -$268K – 1467
2017
Q4 		$268K Sell
19,158
-6,863
-26% -$100K 0.05% 752
2017
Q3 		$372K Buy
+26,021
New +$372K 0.06% 589
2016
Q3 		– Sell
-16,789
Closed -$328K – 1221
2016
Q2 		$328K Buy
+16,789
New +$329K 0.09% 470
2015
Q1 		– Sell
-12,074
Closed -$199K – 930
2014
Q4 		$199K Buy
+12,074
New +$207K 0.1% 492

Other funds holding VIVO

BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Dynamic Technology Lab's VIVO Position: Q1 2023 in Review

Dynamic Technology Lab sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 12,061 shares — an estimated $401K sold.

Dynamic Technology Lab first reported a position in VIVO in Q4 2014 and held it in 9 quarters. The position peaked at $401K in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

  • Dynamic Technology Lab reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
  • Dynamic Technology Lab sold 12,061 Meridian Bioscience Inc shares in Q1 2023, an estimated $401K.
  • Dynamic Technology Lab first reported a position in Meridian Bioscience Inc in Q4 2014 and held it in 9 quarters.
  • Dynamic Technology Lab's Meridian Bioscience Inc position peaked at $401K in Q4 2022.
  • 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Dynamic Technology Lab's 13F filing for Q1 2023, filed 12 May 2023.